Skip to main content
TipRanks
Go Ultimate75% OFF

Excelsior Biopharma Inc (6496) Q2 2025 Earnings Report

TW:6496 Q2 2025 EPS Results

Actual EPS
-TWD 1.04
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-TWD 0.46

TW:6496 Q2 2025 Revenue Results

Actual Revenue
TWD 201.99M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-5.12%

Earnings Announcement Details

Quarter
Q2 2025
Date
08/07/2025
Time
Before Open
Conference Call
Thursday, August 7, 2025
TW:6496 Upcoming Earnings

Excelsior Biopharma Inc's next earnings date is estimated for February 19, 2027, based on past reporting schedules.

Q2 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:6496 Earnings History

TW:6496 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 19, 20272026 (Q4)―--0.85――
Nov 05, 20262026 (Q3)―-0.72-1.1940.03% (+0.48)
May 07, 20262026 (Q1)―-1.18-0.89-32.96% (-0.29)
Feb 12, 20262025 (Q4)―-0.85-0.47-79.87% (-0.38)
Nov 06, 20252025 (Q3)―-1.19-0.48-146.69% (-0.71)
Aug 07, 20252025 (Q2)―-1.04-0.46-128.35% (-0.58)
May 06, 20252025 (Q1)―-0.89-0.73-21.20% (-0.15)
Feb 21, 20252024 (Q4)―-0.470.13-454.89% (-0.60)
Nov 07, 20242024 (Q3)―-0.48-0.8140.25% (+0.33)
Aug 08, 20242024 (Q2)―-0.46-0.7942.33% (+0.33)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed